HS Rheovis AS 1125
HS Rheovis AS 1125
HS Rheovis AS 1125
Rheovis AS 1125 NA
Revision date : 2018/10/24 Page: 1/9
Version: 3.0 (30268342/SDS_GEN_MX/EN)
1. Identification
Rheovis AS 1125 NA
Recommended use of the chemical and restriction on use
* The “Recommended use” identified for this product is provided solely to comply with a Federal requirement and is not part of
the seller's published specification. The terms of this Safety Data Sheet (SDS) do not create or infer any warranty, express or
implied, including by incorporation into or reference in the seller's sales agreement.
Company:
BASF Mexicana S.A. de C.V.
Av. Insurgentes Sur 975
Col. CD. De Los Deportes,
C.P. 03710 Ciudad de México
MÉXICO
2. Hazards Identification
According to Regulation NOM-018-STPS-2015
Label elements
Safety Data Sheet
Rheovis AS 1125 NA
Revision date : 2018/10/24 Page: 2/9
Version: 3.0 (30268342/SDS_GEN_MX/EN)
The product does not require a hazard warning label in accordance with GHS criteria.
No specific dangers known, if the regulations/notes for storage and handling are considered. If the
product adheres to skin, irritation may occur when it dries.
Under the referenced regulation, this product does not contain any components classified for health
hazards above the relevant cut off value.
4. First-Aid Measures
General advice:
Remove contaminated clothing.
If inhaled:
Remove the affected individual into fresh air and keep the person calm. Assist in breathing if
necessary. Immediate medical attention required.
If on skin:
Wash affected areas thoroughly with soap and water. If irritation develops, seek medical attention.
If in eyes:
Flush with copious amounts of water for at least 15 minutes. If irritation develops, seek medical
attention.
If swallowed:
Immediately rinse mouth and then drink plenty of water, do not induce vomiting, seek medical
attention. Never induce vomiting or give anything by mouth if the victim is unconscious or having
convulsions.
Symptoms: No significant symptoms are expected due to the non-classification of the product.
Hazards: No hazards anticipated.
Note to physician
Treatment: Symptomatic treatment (decontamination, vital functions).
5. Fire-Fighting Measures
Extinguishing media
Safety Data Sheet
Rheovis AS 1125 NA
Revision date : 2018/10/24 Page: 3/9
Version: 3.0 (30268342/SDS_GEN_MX/EN)
Further information:
Dispose of fire debris and contaminated extinguishing water in accordance with official regulations.
Product itself is non-combustible; fire extinguishing method of surrounding areas must be
considered.
Environmental precautions
Do not release untreated into natural waters.
Spills should be contained, solidified, and placed in suitable containers for disposal.
Hand protection:
Chemical resistant protective gloves
Eye protection:
Tightly fitting safety goggles (chemical goggles). Wear face shield if splashing hazard exists.
Reactivity
No hazardous reactions if stored and handled as prescribed/indicated.
Corrosion to metals:
Corrosive effects to metal are not anticipated.
Oxidizing properties:
not fire-propagating
Chemical stability
The product is stable if stored and handled as prescribed/indicated.
Conditions to avoid
Avoid extreme heat.
Incompatible materials
metal salts
Decomposition products:
Hazardous decomposition products: carbon dioxide, carbon monoxide, hydrocarbons
Thermal decomposition:
No decomposition if used correctly.
Routes of entry for solids and liquids are ingestion and inhalation, but may include eye or skin
contact. Routes of entry for gases include inhalation and eye contact. Skin contact may be a route
of entry for liquefied gases.
Acute Toxicity/Effects
Acute toxicity
Assessment of acute toxicity: Virtually nontoxic after a single ingestion. Virtually nontoxic after a
single skin contact. Virtually nontoxic by inhalation. Ingestion may cause gastrointestinal
disturbances. The product has not been tested. The statement has been derived from
substances/products of a similar structure or composition.
Safety Data Sheet
Rheovis AS 1125 NA
Revision date : 2018/10/24 Page: 6/9
Version: 3.0 (30268342/SDS_GEN_MX/EN)
Oral
Type of value: LD50
Species: rat
Value: > 2,000 - 10,000 mg/kg
Inhalation
Type of value: ATE
Value: > 5 mg/l
Exposure time: 4 h
Determined for mist
Dermal
Type of value: ATE
Value: > 5,000 mg/kg
Irritation / corrosion
Assessment of irritating effects: Not irritating to eyes and skin. May cause mechanical irritation. If the
product adheres to skin, irritation may occur when it dries. The product has not been tested. The
statement has been derived from substances/products of a similar structure or composition.
Skin
Species: rabbit
Result: non-irritant
Method: OECD Guideline 404
Eye
Species: rabbit
Result: non-irritant
Method: OECD Guideline 405
Sensitization
Assessment of sensitization: Skin sensitizing effects were not observed in animal studies. The
product has not been tested. The statement has been derived from substances/products of a similar
structure or composition.
Aspiration Hazard
not applicable
Chronic Toxicity/Effects
Genetic toxicity
Assessment of mutagenicity: The substance was not mutagenic in bacteria. The product has not
been tested. The statement has been derived from substances/products of a similar structure or
composition.
Carcinogenicity
Safety Data Sheet
Rheovis AS 1125 NA
Revision date : 2018/10/24 Page: 7/9
Version: 3.0 (30268342/SDS_GEN_MX/EN)
Assessment of carcinogenicity: The whole of the information assessable provides no indication of a
carcinogenic effect.
Reproductive toxicity
Assessment of reproduction toxicity: Not expected to cause reproductive toxicity (based on
composition).
Teratogenicity
Assessment of teratogenicity: The data available for an assessment of the effect of the substance on
developmental toxicity are not sufficient for a proper evaluation.
Experiences in humans
According to experience, the product is considered to be harmless to health if used in the correct
manner.
Other Information
Based on our experience and the information available, no adverse health effects are expected if
handled as recommended with suitable precautions for designated uses. The statement was derived
from products of similar composition.
Symptoms of Exposure
Toxicity
Toxicity to fish
LC50 (96 h) > 100 mg/l, Brachydanio rerio (OECD Guideline 203, static)
Aquatic invertebrates
EC50 (48 h) > 100 mg/l, Daphnia magna (OECD Guideline 202, part 1, static)
Aquatic plants
EC50 (72 h) > 100 mg/l, Scenedesmus subspicatus (OECD Guideline 201)
Nominal concentration.
Toxicity to microorganisms
DIN EN ISO 8192-OECD 209-88/302/EEC,P. C activated sludge, domestic/EC20 (0.5 h): > 100 mg/l
The inhibition of the degradation activity of activated sludge is not anticipated when introduced to
biological treatment plants in appropriate low concentrations.
Elimination information
Bioaccumulative potential
Bioaccumulation potential
Based on its structural properties, the polymer is not biologically available. Accumulation in
organisms is not to be expected.
Mobility in soil
Additional information
Container disposal:
Dispose of in a licensed facility. Recommend crushing, puncturing or other means to prevent
unauthorized use of used containers.
Land transport
TDG
Not classified as a dangerous good under transport regulations
Sea transport
IMDG
Not classified as a dangerous good under transport regulations
Air transport
IATA/ICAO
Not classified as a dangerous good under transport regulations
Not applicable
We support worldwide Responsible Care® initiatives. We value the health and safety of our
employees, customers, suppliers and neighbors, and the protection of the environment. Our
commitment to Responsible Care is integral to conducting our business and operating our facilities in
a safe and environmentally responsible fashion, supporting our customers and suppliers in ensuring
the safe and environmentally sound handling of our products, and minimizing the impact of our
operations on society and the environment during production, storage, transport, use and disposal of
our products.
This information is considered accurate but is not exhaustive and shall only be used as a guideline
based on current knowledge of the chemical substance or mixture. Safety precautions suitable for
the product must be applied.